Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Lescol Capsules & Lescol XL (fluvastatin sodium) Extended release Tablets, Novartis Pharmaceutical NDA 20-261/S32 & 21-192/S4 9/6/02 9/11/02 9/6/02 Lescol XL (fluvastatin sodium) Extended release Tablets, Novartis Pharmaceutical NDA 21-192 10/6/00 10/20/00 Lescol XL (fluvastatin sodium) Extended release Tablets, Novartis Pharmaceutical NDA 21-192/S2 9/25/01 5/1/03 Lescol (fluvastatin sodium) capsules, Novartis Pharmaceutical NDA 20-261/S-018 & S-022 3/8/99 6/3/99 Lescol Supplement-018provides for a new indication, the reduction of triglycerides and ApoB in patients with primary hypercholesterolemia and mixed dyslipidemia Lescol Supplement-022provides for a reduction in the recommended frequency of Liver Function Testing (LFT) and eliminates periodic, i.e., semi-annual, LFT monitoring Lescol (fluvastatin sodium) Capsules, Novartis Pharmaceutical NDA 20-261/S-024 10/23/00 11/27/00 11/27/00 Lescol Supplement-024 as an adjunct to diet to reduce elevated total cholesterol (total-C), LDL-C, TG, and Apo B levels, and to increase HDL-C in patients with primary hypercholesterolemia and mixed dyslipidemia (Frederickson Type IIa and IIb) whose response to dietary restriction of saturated fat and cholesterol and other nonpharmacological measures has not been adequate | Lescol (fluvastatin) Capsules, Novartis Pharmaceutical NDA 20-261/S-025 12/19/00 2/20/01 | Lescol (fluvastatin) Capsules, Novartis Pharmaceutical NDA 20-261/S-30 | Lescol (fluvastatin sodium) Capsules, Novartis Pharma, Labeling Revision | Lescol XL (fluvastatin sodium) Extended-Release Tablets | Lescol (fluvastatin sodium) Capsules, Novartis Pharma, Labeling Revision | Lescol XL (fluvastatin sodium) Extended-Release Tablets, Novartis Pharma, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com